chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a physician via a field employee refers to a female patient of unknown age. The concurrent condition and medical history was not reported. On an unknown date the patient was vaccinated with either GARDASIL or GARDASIL 9 (route, dose and lot details unavailable. The concomitant medication was not reported. On an unknown date the patient experienced unspecified adverse event. The field employee could not confirm if the vaccine was GARDASIL or GARDASIL 9. The action taken was not applicable. The outcome of adverse event was unknown. The causality was unspecified. Additional information is not expected as the physician does not wish to be contacted.
First felt chills around 4 hours after the vaccination. Chills were very intense, could not get warm. Took acetaminophen around 1:30am and the chills subsided. Then had a fever of 101 degrees. Head ache started the same time as the chills. The next day I had full body aches, headache, nausea. Symptoms subsided as the day went on. The following day, still had some nausea.
COLITIS SYMPTOMS DID CAME BACK AFTER GOT THE COVID VACCINE; This spontaneous report received from a patient concerned a 73 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included moderate to severe adult crohn's disease, and moderate to severe ulcerative colitis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers.   Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported, and dose, frequency, and therapy dates were not reported for moderate to severe adult crohn's disease, and moderate to severe ulcerative colitis. No concomitant medications were reported. On an unspecified date, the subject experienced colitis symptoms did came back after got the covid vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from colitis symptoms did came back after got the covid vaccine. This report was non-serious.
I was menstruating when I went to receive the 1st dose. My period continued normally for that week. When I went back to receive the 2nd dose I should have been menstruating again but was not. It has now been 7 months and I have not had another period. Nothing else in my life has changed and I am NOT pregnant. I am also not experiencing any of the symptoms of Menopause.
Swelling redness and itching happened immediately and lasted about 4 days.  Large bump under the skin which lasted for a couple of weeks, itching.  Now small bump/swelling under the skin with brown scar on outside.  Sometimes itches.  Sometimes hurts to touch.
The patient stated that about 1 week after the administration of the second dose, she developed a red, itchy rash around her neck and two spots on her face. The rash lasted about 2 weeks. She also complains of her hair falling out which started about 2-3 weeks after the administration and continues now. She specifically stated that nothing else had changed recently in her meds recently.
On Tuesday 11/5/13 - Swollen glands around neck. On Wednesday 11/6/12: Aches from neck to toe - shakes and fever. On Thursday 11/7/13: Swollen arm - swollen face. Red face - fever 105.2 F contacted DR - went to  hospital - picked up prednisone taper. Today 11/8/13 only 50% recovered.
Two days after the injection was given a large red, no pain, itchy rash appeared on the upper arm. 6-8 inches long, 2 1/2 inches wide wrapping around and down the arm. Rash faded after 1 week on ZYRTEC and hydrocortisone cream. 4/18 rash appeared; 4/24 clear.
very upset stomach w/significant vomiting;to ER for fluid replacement;occurred day p/vax;
Pain at injection site; myalgias; arthralgias; fatigue; low grade temp 100.2; This is a spontaneous report received from a contactable reporter (Nurse). The reporter is the patient.  A 63-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 21Oct2023 at 10:30 as dose 1, single (Lot number: HG2282) at the age of 63 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Psoriasis" (unspecified if ongoing); "GERD" (unspecified if ongoing); "migraine" (unspecified if ongoing); "IBS" (unspecified if ongoing); "rosacea" (unspecified if ongoing); "SVT" (unspecified if ongoing). Concomitant medications included: OTEZLA; ESOMEPRAZOLE; CENTRUM SILVER MULTIVITAMIN MULTIMINERAL PLUS LUTEIN & LYCOPENE. Past drug history included: Bactrim and amoxicillin, reaction: "Drug Allergies: Bactrim"; Bactrim and amoxicillin, reaction: "Drug Allergies: Amoxicillin"; Acetaminophen, reaction: "Known allergies: Acetaminophen". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 21Oct2023 at 19:30, outcome "not recovered", described as "Pain at injection site"; ARTHRALGIA (non-serious) with onset 21Oct2023 at 19:30, outcome "not recovered", described as "arthralgias"; FATIGUE (non-serious) with onset 21Oct2023 at 19:30, outcome "not recovered"; PYREXIA (non-serious) with onset 21Oct2023 at 19:30, outcome "not recovered", described as "low grade temp 100.2"; MYALGIA (non-serious) with onset 21Oct2023 at 19:30, outcome "not recovered", described as "myalgias". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vaccination site pain, myalgia, arthralgia, fatigue, pyrexia.
Woke up with an asthma attack, has not had one in two years. She was sweating, hot, and nauseated. She threw up and felt dizzy and the symptoms last for about an hour. She laid down to relieve any symptoms and took Albuterol for her asthma.
DEATH Narrative: Pt he reports he developed chills SOB body aches the same night as receiving the COVID vaccine on 1.26.2021-pt is currently reporting CheSt tightness and SOB Admitted to hosp: ICU with Bilateral Pulmonary Emboli, LLE DVT, NSTEMI, Arrhythmia.
I had the vaccine, two injections/ got the Shingles a few months later/suspected Vaccination failure; got the Shingles/ Not as severe, but still uncomfortable; This case was reported by a consumer via media and described the occurrence of Suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (off and on for years).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, several months after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by patient itself. The age at vaccination was not reported. The patient had 2 shingles vaccine which were expensive and got Shingles few months later after vaccination. The shingles was not as severe, but still it was uncomfortable to patient. This case was considered as suspected vaccination failure as details regarding laboratory confirmation was unknown at the time of reporting .
Fever 101, chills, fatigue, body soreness - duration 12 hours, onset of symptoms about 18 hours after vaccine.  Then quickly passed.  arm soreness - 48 hours
Coagulation system disorder - did not clot the blood. normal CBC but no clot. lack of coagulation.   not cicatrization of wound - in take one month and a half to cicatrization a a minor cut. it blled for 1 month and a half.   extended bleeding time for 4 months.  lack of movements in lower extremity for 3 days
This case was reported by a nurse via other manufacturer and described the occurrence of rash in a patient who received dTpa vaccine. On an unknown date, the patient received dTpa vaccine at an unknown dose. On an unknown date, an unknown time after receiving dTpa vaccine, the patient experienced rash and itching. On an unknown date, the outcome of the rash and itching were unknown. It was unknown if the reporter considered the rash and itching to be related to dTpa vaccine.
04/13/2021 - 03:30 PM - chills and feverish 04/13/2021 - later that night - severe chills like cold pulse originating from the toes and fever 04/14/2021 - 12.00 PM - reduced fever, chills reduced, tiredness 04/15/2021 - 1.30 AM  to 6.00 AM - Severe chest pain,  04/15/2021 - 8.30 AM reduces pain 04/15/2021 - 11.30 AM self medicate Gas-X capsule  04/15/2021 - 1.30 PM self medicate Gas-X capsule
ALMOST BLACKED OUT; ACHES; HEADACHE; FATIGUE; DEHYDRATED; This spontaneous report received from a patient. The patient's height, and weight were not reported. The patient's past medical history included surgery to the ankle. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On MAR-2021, the subject experienced dehydrated. On 24-MAR-2021, the subject experienced aches. On 24-MAR-2021, the subject experienced headache. On 24-MAR-2021, the subject experienced fatigue. On 27-MAR-2021, the subject experienced almost blacked out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from aches, headache, and almost blacked out, and the outcome of fatigue and dehydrated was not reported. This report was non-serious.; Sender's Comments: V0 : medical assessment comment not required as per standard procedure as the case assessed as non serious
I had my second vaccination yesterday of SHINGRIX. Both times I had flu like symptoms. The first time they lasted about 2 days. Chills. Possibly a fever as I sure felt like I did. Weak and tired, no energy. Headache. A little of upset stomach, not bad. I had the shot about 30 hours ago and I started feeling better at about the 24 hour mark. I still feel a bit off, weak and tired, but I am at work at my desk job. I took this morning off.
Information has been received from a registered nurse concerning a female patient (age not reported) patient who was vaccinated with one dose of PNEUMOVAX 23 (lot # 662667/1435X). The patient had cellulitis like arm reactions after the vaccination. It was unknown if the patients had sought any medical attention. A lot check for PNEUMOVAX 23 was requested. Follow up information has been received from the registered nurse practitioner who reported that the female patient had reactions of injection site pain, body aches, headaches and dizziness. Subsequently, on an unspecified date recovered. This is one of several reports received from the same source. A standard lot check investigation was performed for lot no. 662667/1435X. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements and was released. This is one of several reports from the same source. Additional information has been requested.
This is a 75-year-old female with a history of hypertension, diabetes and asthma, who completed vaccination against COVID-19 in April, presented with a fever.  Onset was 3 days ago.  Today she noticed a cough and shortness of breath, and so she presented to the ER as well.  Her appetite has been poor for the past 3 days as well.  In the ER, she tested positive for COVID-19.  Her husband also tested positive.
high fever of 107.9; This spontaneous case was reported by a consumer and describes the occurrence of HYPERPYREXIA (high fever of 107.9) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 063A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERPYREXIA (high fever of 107.9) (seriousness criterion medically significant). At the time of the report, HYPERPYREXIA (high fever of 107.9) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 107.9 (High) after the second dose.         Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient states he took a cold shower and went to the emergency room after his fever was 107.9. The patient states he had reactions to both of the Moderna shots. He wants to know if he should get the booster. He would hate to go through the same adverse reaction that he had from the first two shots.  Company Comment: This report concerns a 52 year old male patient with past medical history of COVID-19 who experienced a serious unexpected event of high fever of 107.9 (hyperpyrexia). The event occurred unknown duration after vaccination with second dose of mRNA-1273. The patient reports having high fever of 104.1 unknown duration after the first dose of mRNA-1273 too. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2021-320983 (Patient Link).; Sender's Comments: This report concerns a 52 year old male patient with past medical history of COVID-19 who experienced a serious unexpected event of high fever of 107.9 (hyperpyrexia). The event occurred unknown duration after vaccination with second dose of mRNA-1273. The patient reports having high fever of 104.1 unknown duration after the first dose of mRNA-1273 too. The benefit-risk relationship of mRNA-1273 is not affected by this report.
pain in her hand unable to use it for a few days; This is a spontaneous report from a non-contactable nurse reporting for herself  An adult female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration single dose on 04Jan2021 for covid-19 immunisation. Medical history was none. Concomitant medication included ibuprofen. The patient experienced pain in her hand unable to use it for a few days on Jan2021. Therapeutic measures included tylenol. SARS-Cov-2 test nasal swab in Jan2021 was negative. The outcome was recovered  Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information, a possible contributory role of the suspect product BNT162B2 to the development of event Pain in hand cannot be excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
At first I only had a sore arm. By early Friday evening, the night after the vaccination, I began having severe steady pain in my left kidney, along with sharp shooting pain at the same location.  I also had the expected headache and fatigue. I took Tylenol during this time, and still am. I was pretty much totally bed-ridden for 4 days.  I called my doctor on Wednesday, February 17th to report the severe reaction in my left kidney. The nurse told me that as long as I felt better each day then to weather it out and get  the second shot (scheduled for March 11).  Although I am feeling a little better, I am still taking Tylenol for the pain in my kidney. My exhaustion is lessening.
Red, Measles-like rash on face 14 days after vaccination, lasting for 5 days. No fever
Dizziness, still currently feeling; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 17:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, hypertension, depression and known allergies to strawberries and apples. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), sertraline hydrochloride (ZOLOFT), montelukast sodium (SINGULAIR), fluticasone (MANUFACTURER UNKNOWN) and diltiazem hydrochloride (DILTIA); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 14:00, the patient experienced dizziness and was still currently feeling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness, still currently feeling was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms; 38 have improvement of symptoms; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (38 have improvement of symptoms) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms), THERAPEUTIC RESPONSE UNEXPECTED (38 have improvement of symptoms) and NO ADVERSE EVENT (No adverse event). At the time of the report, OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms) had resolved and THERAPEUTIC RESPONSE UNEXPECTED (38 have improvement of symptoms) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for OFF LABEL USE (Administered Moderna Covid-19 Bivalent doses to treat long-haul COVID symptoms) and THERAPEUTIC RESPONSE UNEXPECTED (38 have improvement of symptoms).    No concomitant medications were reported. No treatment medications were provided.  Patient 31 out of 42 patients   This case was linked to US-MODERNATX, INC.-MOD-2023-735199 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735199:Patient 31 out of 42 patients
BLOOD DOTS ON BOTH ARMS; HEADACHE; ITCHING; BIG RED BLOTCH ON SKIN/ BIG BLOOD BLOTCH ON SKIN; This spontaneous report received from a patient concerned a 67 year old female. The patient's weight was 112 pounds, and height was 63 inches. The patient's past medical history included smoker, and concurrent conditions included chronic obstructive pulmonary disease, reflex sympathetic dystrophy, arthritis, gastrooesophageal reflux disease, fibromyalgia, and non alcohol user, and other pre-existing medical conditions included patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with pethidine hydrochloride, ibuprofen, lansoprazole, loratadine, pregabalin, naproxen, and aluminium hydroxide/magnesium hydroxide/simeticone for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and batch number: 203A21A expiry: 23-JUN-2021) dose was not reported, administered on 28-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced itching. On 2021, the subject experienced big red blotch on skin/ big blood blotch on skin. On 29-MAY-2021, the subject experienced blood dots on both arms. On 29-MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 29-MAY-2021, and the outcome of blood dots on both arms, big red blotch on skin/ big blood blotch on skin and itching was not reported. This report was non-serious.
Pfizer covid vaccine was administered on day 33 of refrigeration. Current manufacturer limit is 31 days. Patient was offered revaccination. And proper labelling of stored vaccine has been enforced.
Day 1 post vaccine, full body aches, joint paint, fever, headache, lethargy, malaise. Day 2, post vaccine redness / rash at injection site
Red Hives all over body but face. Severe looking. Also fever, chills, intense itching.
Pain and discomfort in my right upper side under my ribcage on evening of 12/1 and 12/2 (also had some chills as I went to sleep), so on 12/3, I called my gastroenterologist and told him of my symptoms and I had been diagnosed by CT Scan of having a 1.3cm gallstone, so Dr. had me go to the ER at 10:30am on 12/3 to rule out any serious complications from the gallstone in event I needed it removed.  I drove myself to the ER and was triaged.  They drew blood and took my vitals, which were all normal.  I also had an ultrasound done which showed the gallstone but no inflammation of the gallbladder although the area was sensitive while the tech performed the ultrasound which she noted in her report.  My bloodwork was all normal besides my ALT was 80, which nobody mentioned at the ER.  The ER doctor released me as I didn't meet the criteria to be admitted or to have my gallbladder removed urgently.  Both ER doctor and my gastroenterologist advised me to eat a low fat diet to avoid any flareups.  My gastroenterologist referred me to a surgeon who I am seeing on 12/9/21.  Since I have controlled my diet, I have not had any pain or discomfort in that area.
This patient presented with fussiness and a bloody diaper and was found to have intussusception which could not be corrected with contrast enema and required surgical reduction.  No ischemia or necrosis was found.